Abstract
The inherited bone marrow failure syndromes are a heterogeneous group of disorders characterized by bone marrow failure which may or may not be associated with one or more somatic abnormality. The bone marrow failure can involve all or a single cell lineage resulting in pancytopenia or single cytopenias, respectively. Their true incidence is not clear since most of them are misdiagnosed as cases of acquired aplastic anemia. These syndromes often present in childhood but may not do so until adulthood in some cases. Inherited marrow failure syndromes need to be considered in the differential diagnosis of patients with characteristic physical abnormalities when present, along with idiopathic aplastic anemia, myelodysplastic syndrome, acute myeloid leukemia, or other characteristic solid cancers at an unusually early age. Diagnosis is confirmed by the identification of pathogenic mutations associated with each syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski’s hematology of infancy and childhood. Philadelphia: W.B. Saunders; 2003.
Verlander PC, Kaporis A, Liu Q, Zhang Q, Seligsohn U, Auerbach AD. Carrier frequency of the IVS4 + 4 AT mutation of the Fanconi anemia gene FANC in the Ashkenazi Jewish population. Blood. 1995;86:4034–8.
Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241–8.
Lobitz S, Velleuer E. Guido Fanconi (1892-1979): a jack of all trades. Nat Rev Cancer. 2006;6(11):893–8.
Faivre L, Guardiola P, Lewis C, et al. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood. 2000;96:4064.
D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23.
Litman R, Peng M, Jin Z, et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell. 2005;8:255.
Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162.
De Rocco D, Bottega R, Cappelli E, et al. Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology. Haematologica. 2014;99:1022.
Hira A, Yoshida K, Sato K, et al. Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am J Hum Genet. 2015;96:1001.
Dong H, Nebert DW, Bruford EA, et al. Update of the human and mouse Fanconi anemia genes. Hum Genomics. 2015;9:32.
Rickman KA, Lach FP, Abhyankar A, et al. Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of Fanconi anemia. Cell Rep. 2015;12:35.
Virts EL, Jankowska A, Mackay C, et al. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum Mol Genet. 2015;24:5093.
Sawyer SL, Tian L, Kähkönen M, et al. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov. 2015;5:135.
Wang AT, Kim T, Wagner JE, et al. A dominant mutation in human RAD51 reveals its function in DNA interstrand crosslink repair independent of homologous recombination. Mol Cell. 2015;59:478.
Ameziane N, May P, Haitjema A, et al. A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51. Nat Commun. 2015;6:8829.
Park JY, Virts EL, Jankowska A, et al. Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene. J Med Genet. 2016;53:672.
Wang W. Emergence of a DNA-damage response network consisting of Fanconianaemia and BRCA proteins. Nat Rev Genet. 2007;8:735.
Meetei AR, Levitus M, Xue Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet. 2004;36:1219.
Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature. 2013 Jan 17;493(7432):356–63.
Giampietro PF, Adler-Brecher B, Verlander PC, Pavlakis SG, Davis JG, Auerbach AD. The need for more accurate and timely diagnosis in Fanconi anemia. A report from the International Fanconi Anemia Registry. Paediatrics. 1993;91:1116–20.
Alter BP. Fanconi anemia and the development of leukemia. Best Pract Res Clin Haematol. 2014;27:214.
Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer. 2003;97:425.
Oostra AB, Nieuwint AWM, Joenje H, de Winter JP. Diagnosis of Fanconi anemia: chromosomal breakage analysis. Anemia. 2012;2012:238731.
Bertuch AA. The molecular genetics of the telomere biology disorders. RNA Biol. 2016;13:696.
Horiguchi N, Kakizaki S, Iizuka K, et al. Hepatic angiosarcoma with dyskeratosis congenita. Intern Med. 2015;54:2867.
Woloszynek JR, Rothbaum RJ, Rawls AS, et al. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood. 2004;104:3588.
Dror Y, Donadieu J, Koglmeier J, et al. Draft consensus guidelines for diagnosis and treatment of syndrome. Ann N Y Acad Sci. 2011;1242:40.
King S, Germeshausen M, Strauss G, Welte K, Ballmaier M. Congenital amegakaryocytic thrombocytopenia (CAMT): a detailed clinical analysis of 21 cases reveal different types of CAMT. Blood/ASH Annual Meeting abstracts 2004; abstract 740; 2005. Dec, 2004. American Society of Hematology.
Rose MJ, Nicol KK, Skeens MA, Gross TG, Kerlin BA. Congenital amegakaryocytic thrombocytopenia: the diagnostic importance of combining pathology with molecular genetics. Pediatr Blood Cancer. 2008;50:1263–5.
Gazda HT, Zhong R, Long L, Niewiadomska E, Lipton JM, Ploszynska A, et al. RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol. 2004;127:105–13.
Gazda HT, Grabowska A, Merida-Long LB, Latawiec E, Schneider HE, Lipton JM, et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2006;79:1110–8.
Vlachos A, Ball S, Niklas D, Alter BP, Sheth S, Ugo R, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an International Clinical Consensus Conference; 2008. p. 1365–2141.
Lipton JM, Ellis SR. Diamond Blackfan anemia: diagnosis, treatment and molecular pathogenesis. Hematol Oncol Clin North Am. 2009;23(2):261–82.
Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol. 2006;43(3):189–95.
Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96(7):2317–22.
Ward AC. The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease. Front Biosci. 2007;12:608–18.
Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schaffer AA, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39(1):86–92.
Alter BP, D’Andrea AD. Inherited bone marrow failure syndromes. In: Handin RI, Lux SE, Stossel TP, editors. Blood: principles and practice of hematology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 209–72.
Bonsi L, Marchionni C, Alviano F, Lanzoni G, Franchini M, Costa R. Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease? Exp Hematol. 2009;37:1–7.
Letestu R, Vitrat N, Massé A. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. Blood. 2000;95:1633–41.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Karthika, K.V., Mishra, P., Pati, H.P. (2019). Inherited Bone Marrow Failure Syndromes. In: Saxena, R., Pati, H. (eds) Hematopathology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7713-6_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-7713-6_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7712-9
Online ISBN: 978-981-13-7713-6
eBook Packages: MedicineMedicine (R0)